VPS4B orchestrates response to nuclear envelope stress by regulating ESCRT-III dynamics in glioblastoma

Nucleus. 2024 Dec;15(1):2423660. doi: 10.1080/19491034.2024.2423660. Epub 2024 Nov 14.

Abstract

The Nuclear envelope (NE) is frequently challenged by mechanical stimuli involving cells passing through a tight space and such stress is known as "NE stress." Various factors that cooperate to repair the NE have been identified, including endosomal sorting complex required for transport-III (ESCRT-III). Recently, vacuolar protein sorting 4 homolog B (VPS4B) has been reported to modulate the recycling of ESCRT-III during NE repair, but the regulatory mechanism remains unclear. Our previous study revealed that U251MG cells, derived from the glioblastoma (GBM), exhibited nuclear deformation followed by DNA damage upon mechanical NE stress while these phenotypes were not observed in U87MG, another GBM-derived cell line. Here, we found that VPS4B expression was lower in U251MG than in U87MG. Our functional analysis demonstrated that insufficient VPS4B triggers an inadequate response to NE stress and that VPS4B regulates the dynamics of ESCRT-III, uncovering the mechanism underlying the NE stress response in GBM.

Keywords: ESCRT-III; VPS4B; glioblastoma; nuclear envelope; nuclear envelope stress.

MeSH terms

  • ATPases Associated with Diverse Cellular Activities / genetics
  • ATPases Associated with Diverse Cellular Activities / metabolism
  • Cell Line, Tumor
  • Endosomal Sorting Complexes Required for Transport* / genetics
  • Endosomal Sorting Complexes Required for Transport* / metabolism
  • Glioblastoma* / genetics
  • Glioblastoma* / metabolism
  • Glioblastoma* / pathology
  • Humans
  • Nuclear Envelope* / metabolism
  • Stress, Physiological

Substances

  • Endosomal Sorting Complexes Required for Transport
  • VPS4B protein, human
  • ATPases Associated with Diverse Cellular Activities

Grants and funding

This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI [24K18486, 23K19541, 23K17413, 22K06129], the Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science, The Naito Foundation, Japan Research Foundation for Clinical Pharmacology, Princess Takamatsu Cancer Research Fund, Takeda Science Foundation, Grant of The Clinical Research Promotion Foundation 2023, and Foundation for Promotion of Cancer Research.